04/28/2008 L.A. Times: "Gene Therapy Improves Lost Vision"....more 04/26/2008 The Indo-US Chamber of Commerce honors TransGenex founder with the International Business Person of the Year Award ....more 04/01/2008 TransGenex Nanobiotech Inc. profiled in "The In Vivo Blog"....more 10/08/2007 John Luca...

Related Publications Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, Lockey RF, Mohapatra SS. Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery. Pharm Res. 2007 Jan;24(1):157-167. Epub 2006 Nov 14. PMID: 17103334 Kumar A, Aravamudhan S, Gordic M, Bhansali S, Mohapa...

TransGenex Nanobiotech, Inc. 13719 N. Nebraska Ave., Suite 108 Tampa, FL, 33613 Ph: (813) 975-9649 Fax: (813) 975-9649 E-mails: transgenex@transgenex.com ceo@transgenex.com Copyright 2003, TransGenex Therapeutics (see Website Agreement) ...

Market The target market segments include in vitro diagnostics for HIV and cancers, and nanoparticle therapeutics for cancers, asthma and chronic respiratory diseases. The Global market size for these target segments was $100 billion in 2003 and is expected to double in size within the next 10 years...

Strategic Outlook TGN s business strategy involves both short- and long-term objectives that will generate revenue in the present and facilitate future R & D. TGN continues to generate revenue from the sales of custom nanoparticles and Nanogene reagents and Federal and State grant-funding mecha...